Parafibromin inhibits cancer cell growth and causes G1 phase arrest
Authors:
- Dong KongDKDong Kong
- Min-Han TanMTMin-Han Tan
- Donald L. PappasDPDonald L. Pappas
- Peng-Fei WangPWPeng-Fei Wang
- Jindong ChenJCJindong Chen
- Leslie FarberLFLeslie Farber
- Nian ZhangNZNian Zhang
- Han-Mo KooHKHan-Mo Koo
- Michael WeinreichMWMichael Weinreich
- Bart O. WilliamsBWBart O. Williams
- Bin Tean TehBTBin Tean Teh
- 1 November 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 350 (1) , 17-24
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Loss of parafibromin expression in a subset of parathyroid adenomasEndocrine-Related Cancer, 2006
- Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism–jaw tumour syndromeClinical Endocrinology, 2006
- Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibrominOncogene, 2005
- HRPT2 mutations are associated with malignancy in sporadic parathyroid tumoursJournal of Medical Genetics, 2003
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndromeNature Genetics, 2002
- Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damageNature, 2002
- RNA Polymerase II Elongation Factors of Saccharomyces cerevisiae: a Targeted Proteomics ApproachMolecular and Cellular Biology, 2002
- Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein ResponseJournal of Biological Chemistry, 2001
- Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell CycleScience, 1996
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993